+1 347 708 0418
Circulating Tumor Cells (CTC) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells (CTC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel
Segment by Application
Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others
By Company
AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ex-Vivo Positive Selection
1.2.3 In-Vivo Positive Selection
1.2.4 Negative Selection
1.2.5 Microchips & Single Spiral Micro Channel
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Tumorigenesis Research
1.3.3 Emt Biomarkers Development
1.3.4 Cancer Stem Cell Research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTC) Market Perspective (2017-2028)
2.2 Circulating Tumor Cells (CTC) Growth Trends by Region
2.2.1 Circulating Tumor Cells (CTC) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Circulating Tumor Cells (CTC) Historic Market Size by Region (2017-2022)
2.2.3 Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2023-2028)
2.3 Circulating Tumor Cells (CTC) Market Dynamics
2.3.1 Circulating Tumor Cells (CTC) Industry Trends
2.3.2 Circulating Tumor Cells (CTC) Market Drivers
2.3.3 Circulating Tumor Cells (CTC) Market Challenges
2.3.4 Circulating Tumor Cells (CTC) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTC) Players by Revenue (2017-2022)
3.1.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Players (2017-2022)
3.2 Global Circulating Tumor Cells (CTC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cells (CTC) Revenue
3.4 Global Circulating Tumor Cells (CTC) Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTC) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTC) Revenue in 2021
3.5 Circulating Tumor Cells (CTC) Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cells (CTC) Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cells (CTC) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells (CTC) Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Type (2017-2022)
4.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2023-2028)
5 Circulating Tumor Cells (CTC) Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTC) Historic Market Size by Application (2017-2022)
5.2 Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Circulating Tumor Cells (CTC) Market Size (2017-2028)
6.2 North America Circulating Tumor Cells (CTC) Market Size by Type
6.2.1 North America Circulating Tumor Cells (CTC) Market Size by Type (2017-2022)
6.2.2 North America Circulating Tumor Cells (CTC) Market Size by Type (2023-2028)
6.2.3 North America Circulating Tumor Cells (CTC) Market Share by Type (2017-2028)
6.3 North America Circulating Tumor Cells (CTC) Market Size by Application
6.3.1 North America Circulating Tumor Cells (CTC) Market Size by Application (2017-2022)
6.3.2 North America Circulating Tumor Cells (CTC) Market Size by Application (2023-2028)
6.3.3 North America Circulating Tumor Cells (CTC) Market Share by Application (2017-2028)
6.4 North America Circulating Tumor Cells (CTC) Market Size by Country
6.4.1 North America Circulating Tumor Cells (CTC) Market Size by Country (2017-2022)
6.4.2 North America Circulating Tumor Cells (CTC) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTC) Market Size (2017-2028)
7.2 Europe Circulating Tumor Cells (CTC) Market Size by Type
7.2.1 Europe Circulating Tumor Cells (CTC) Market Size by Type (2017-2022)
7.2.2 Europe Circulating Tumor Cells (CTC) Market Size by Type (2023-2028)
7.2.3 Europe Circulating Tumor Cells (CTC) Market Share by Type (2017-2028)
7.3 Europe Circulating Tumor Cells (CTC) Market Size by Application
7.3.1 Europe Circulating Tumor Cells (CTC) Market Size by Application (2017-2022)
7.3.2 Europe Circulating Tumor Cells (CTC) Market Size by Application (2023-2028)
7.3.3 Europe Circulating Tumor Cells (CTC) Market Share by Application (2017-2028)
7.4 Europe Circulating Tumor Cells (CTC) Market Size by Country
7.4.1 Europe Circulating Tumor Cells (CTC) Market Size by Country (2017-2022)
7.4.2 Europe Circulating Tumor Cells (CTC) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size (2017-2028)
8.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Type
8.2.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Share by Type (2017-2028)
8.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Application
8.3.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Circulating Tumor Cells (CTC) Market Share by Application (2017-2028)
8.4 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region
8.4.1 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Circulating Tumor Cells (CTC) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTC) Market Size (2017-2028)
9.2 Latin America Circulating Tumor Cells (CTC) Market Size by Type
9.2.1 Latin America Circulating Tumor Cells (CTC) Market Size by Type (2017-2022)
9.2.2 Latin America Circulating Tumor Cells (CTC) Market Size by Type (2023-2028)
9.2.3 Latin America Circulating Tumor Cells (CTC) Market Share by Type (2017-2028)
9.3 Latin America Circulating Tumor Cells (CTC) Market Size by Application
9.3.1 Latin America Circulating Tumor Cells (CTC) Market Size by Application (2017-2022)
9.3.2 Latin America Circulating Tumor Cells (CTC) Market Size by Application (2023-2028)
9.3.3 Latin America Circulating Tumor Cells (CTC) Market Share by Application (2017-2028)
9.4 Latin America Circulating Tumor Cells (CTC) Market Size by Country
9.4.1 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2017-2022)
9.4.2 Latin America Circulating Tumor Cells (CTC) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size (2017-2028)
10.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Type
10.2.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Share by Type (2017-2028)
10.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Application
10.3.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Circulating Tumor Cells (CTC) Market Share by Application (2017-2028)
10.4 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country
10.4.1 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Circulating Tumor Cells (CTC) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AdnaGen
11.1.1 AdnaGen Company Details
11.1.2 AdnaGen Business Overview
11.1.3 AdnaGen Circulating Tumor Cells (CTC) Introduction
11.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2017-2022)
11.1.5 AdnaGen Recent Developments
11.2 Apocell
11.2.1 Apocell Company Details
11.2.2 Apocell Business Overview
11.2.3 Apocell Circulating Tumor Cells (CTC) Introduction
11.2.4 Apocell Revenue in Circulating Tumor Cells (CTC) Business (2017-2022)
11.2.5 Apocell Recent Developments
11.3 Biocep
11.3.1 Biocep Company Details
11.3.2 Biocep Business Overview
11.3.3 Biocep Circulating Tumor Cells (CTC) Introduction
11.3.4 Biocep Revenue in Circulating Tumor Cells (CTC) Business (2017-2022)
11.3.5 Biocep Recent Developments
11.4 Canopus Bioscience
11.4.1 Canopus Bioscience Company Details
11.4.2 Canopus Bioscience Business Overview
11.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Introduction
11.4.4 Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2017-2022)
11.4.5 Canopus Bioscience Recent Developments
11.5 Creatv Microtech
11.5.1 Creatv Microtech Company Details
11.5.2 Creatv Microtech Business Overview
11.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Introduction
11.5.4 Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2017-2022)
11.5.5 Creatv Microtech Recent Developments
11.6 Ikonisys
11.6.1 Ikonisys Company Details
11.6.2 Ikonisys Business Overview
11.6.3 Ikonisys Circulating Tumor Cells (CTC) Introduction
11.6.4 Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2017-2022)
11.6.5 Ikonisys Recent Developments
11.7 IV Diagnostics
11.7.1 IV Diagnostics Company Details
11.7.2 IV Diagnostics Business Overview
11.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Introduction
11.7.4 IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2017-2022)
11.7.5 IV Diagnostics Recent Developments
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Company Details
11.8.2 Miltenyi Biotech Business Overview
11.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Introduction
11.8.4 Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2017-2022)
11.8.5 Miltenyi Biotech Recent Developments
11.9 Nanostring Technologies
11.9.1 Nanostring Technologies Company Details
11.9.2 Nanostring Technologies Business Overview
11.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Introduction
11.9.4 Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2017-2022)
11.9.5 Nanostring Technologies Recent Developments
11.10 Rarecells Diagnostics
11.10.1 Rarecells Diagnostics Company Details
11.10.2 Rarecells Diagnostics Business Overview
11.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Introduction
11.10.4 Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2017-2022)
11.10.5 Rarecells Diagnostics Recent Developments
11.11 Vitatex
11.11.1 Vitatex Company Details
11.11.2 Vitatex Business Overview
11.11.3 Vitatex Circulating Tumor Cells (CTC) Introduction
11.11.4 Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2017-2022)
11.11.5 Vitatex Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Ex-Vivo Positive Selection
Table 3. Key Players of In-Vivo Positive Selection
Table 4. Key Players of Negative Selection
Table 5. Key Players of Microchips & Single Spiral Micro Channel
Table 6. Global Circulating Tumor Cells (CTC) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Circulating Tumor Cells (CTC) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Circulating Tumor Cells (CTC) Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Circulating Tumor Cells (CTC) Market Share by Region (2017-2022)
Table 10. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Circulating Tumor Cells (CTC) Market Share by Region (2023-2028)
Table 12. Circulating Tumor Cells (CTC) Market Trends
Table 13. Circulating Tumor Cells (CTC) Market Drivers
Table 14. Circulating Tumor Cells (CTC) Market Challenges
Table 15. Circulating Tumor Cells (CTC) Market Restraints
Table 16. Global Circulating Tumor Cells (CTC) Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Circulating Tumor Cells (CTC) Revenue Share by Players (2017-2022)
Table 18. Global Top Circulating Tumor Cells (CTC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2021)
Table 19. Ranking of Global Top Circulating Tumor Cells (CTC) Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTC) Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Circulating Tumor Cells (CTC) Product Solution and Service
Table 23. Date of Enter into Circulating Tumor Cells (CTC) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Circulating Tumor Cells (CTC) Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2017-2022)
Table 27. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Circulating Tumor Cells (CTC) Revenue Market Share by Type (2023-2028)
Table 29. Global Circulating Tumor Cells (CTC) Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Circulating Tumor Cells (CTC) Revenue Share by Application (2017-2022)
Table 31. Global Circulating Tumor Cells (CTC) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Circulating Tumor Cells (CTC) Revenue Share by Application (2023-2028)
Table 33. North America Circulating Tumor Cells (CTC) Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Circulating Tumor Cells (CTC) Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Circulating Tumor Cells (CTC) Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Circulating Tumor Cells (CTC) Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Circulating Tumor Cells (CTC) Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Circulating Tumor Cells (CTC) Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Circulating Tumor Cells (CTC) Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Circulating Tumor Cells (CTC) Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Circulating Tumor Cells (CTC) Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Circulating Tumor Cells (CTC) Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Circulating Tumor Cells (CTC) Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Circulating Tumor Cells (CTC) Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Circulating Tumor Cells (CTC) Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Circulating Tumor Cells (CTC) Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Circulating Tumor Cells (CTC) Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Circulating Tumor Cells (CTC) Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Circulating Tumor Cells (CTC) Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Circulating Tumor Cells (CTC) Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Circulating Tumor Cells (CTC) Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Circulating Tumor Cells (CTC) Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Circulating Tumor Cells (CTC) Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Circulating Tumor Cells (CTC) Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Circulating Tumor Cells (CTC) Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Circulating Tumor Cells (CTC) Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Circulating Tumor Cells (CTC) Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Circulating Tumor Cells (CTC) Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Circulating Tumor Cells (CTC) Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Circulating Tumor Cells (CTC) Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Circulating Tumor Cells (CTC) Market Size by Country (2023-2028) & (US$ Million)
Table 63. AdnaGen Company Details
Table 64. AdnaGen Business Overview
Table 65. AdnaGen Circulating Tumor Cells (CTC) Product
Table 66. AdnaGen Revenue in Circulating Tumor Cells (CTC) Business (2017-2022) & (US$ Million)
Table 67. AdnaGen Recent Developments
Table 68. Apocell Company Details
Table 69. Apocell Business Overview
Table 70. Apocell Circulating Tumor Cells (CTC) Product
Table 71. Apocell Revenue in Circulating Tumor Cells (CTC) Business (2017-2022) & (US$ Million)
Table 72. Apocell Recent Developments
Table 73. Biocep Company Details
Table 74. Biocep Business Overview
Table 75. Biocep Circulating Tumor Cells (CTC) Product
Table 76. Biocep Revenue in Circulating Tumor Cells (CTC) Business (2017-2022) & (US$ Million)
Table 77. Biocep Recent Developments
Table 78. Canopus Bioscience Company Details
Table 79. Canopus Bioscience Business Overview
Table 80. Canopus Bioscience Circulating Tumor Cells (CTC) Product
Table 81. Canopus Bioscience Revenue in Circulating Tumor Cells (CTC) Business (2017-2022) & (US$ Million)
Table 82. Canopus Bioscience Recent Developments
Table 83. Creatv Microtech Company Details
Table 84. Creatv Microtech Business Overview
Table 85. Creatv Microtech Circulating Tumor Cells (CTC) Product
Table 86. Creatv Microtech Revenue in Circulating Tumor Cells (CTC) Business (2017-2022) & (US$ Million)
Table 87. Creatv Microtech Recent Developments
Table 88. Ikonisys Company Details
Table 89. Ikonisys Business Overview
Table 90. Ikonisys Circulating Tumor Cells (CTC) Product
Table 91. Ikonisys Revenue in Circulating Tumor Cells (CTC) Business (2017-2022) & (US$ Million)
Table 92. Ikonisys Recent Developments
Table 93. IV Diagnostics Company Details
Table 94. IV Diagnostics Business Overview
Table 95. IV Diagnostics Circulating Tumor Cells (CTC) Product
Table 96. IV Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2017-2022) & (US$ Million)
Table 97. IV Diagnostics Recent Developments
Table 98. Miltenyi Biotech Company Details
Table 99. Miltenyi Biotech Business Overview
Table 100. Miltenyi Biotech Circulating Tumor Cells (CTC) Product
Table 101. Miltenyi Biotech Revenue in Circulating Tumor Cells (CTC) Business (2017-2022) & (US$ Million)
Table 102. Miltenyi Biotech Recent Developments
Table 103. Nanostring Technologies Company Details
Table 104. Nanostring Technologies Business Overview
Table 105. Nanostring Technologies Circulating Tumor Cells (CTC) Product
Table 106. Nanostring Technologies Revenue in Circulating Tumor Cells (CTC) Business (2017-2022) & (US$ Million)
Table 107. Nanostring Technologies Recent Developments
Table 108. Rarecells Diagnostics Company Details
Table 109. Rarecells Diagnostics Business Overview
Table 110. Rarecells Diagnostics Circulating Tumor Cells (CTC) Product
Table 111. Rarecells Diagnostics Revenue in Circulating Tumor Cells (CTC) Business (2017-2022) & (US$ Million)
Table 112. Rarecells Diagnostics Recent Developments
Table 113. Vitatex Company Details
Table 114. Vitatex Business Overview
Table 115. Vitatex Circulating Tumor Cells (CTC) Product
Table 116. Vitatex Revenue in Circulating Tumor Cells (CTC) Business (2017-2022) & (US$ Million)
Table 117. Vitatex Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cells (CTC) Market Share by Type: 2021 VS 2028
Figure 2. Ex-Vivo Positive Selection Features
Figure 3. In-Vivo Positive Selection Features
Figure 4. Negative Selection Features
Figure 5. Microchips & Single Spiral Micro Channel Features
Figure 6. Global Circulating Tumor Cells (CTC) Market Share by Application: 2021 VS 2028
Figure 7. Tumorigenesis Research Case Studies
Figure 8. Emt Biomarkers Development Case Studies
Figure 9. Cancer Stem Cell Research Case Studies
Figure 10. Others Case Studies
Figure 11. Circulating Tumor Cells (CTC) Report Years Considered
Figure 12. Global Circulating Tumor Cells (CTC) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Circulating Tumor Cells (CTC) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Circulating Tumor Cells (CTC) Market Share by Region: 2021 VS 2028
Figure 15. Global Circulating Tumor Cells (CTC) Market Share by Players in 2021
Figure 16. Global Top Circulating Tumor Cells (CTC) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTC) as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTC) Revenue in 2021
Figure 18. North America Circulating Tumor Cells (CTC) Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Circulating Tumor Cells (CTC) Market Size Market Share by Type (2017-2028)
Figure 20. North America Circulating Tumor Cells (CTC) Market Size Market Share by Application (2017-2028)
Figure 21. North America Circulating Tumor Cells (CTC) Market Size Share by Country (2017-2028)
Figure 22. United States Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Circulating Tumor Cells (CTC) Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Circulating Tumor Cells (CTC) Market Size Market Share by Type (2017-2028)
Figure 26. Europe Circulating Tumor Cells (CTC) Market Size Market Share by Application (2017-2028)
Figure 27. Europe Circulating Tumor Cells (CTC) Market Size Share by Country (2017-2028)
Figure 28. Germany Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Circulating Tumor Cells (CTC) Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Circulating Tumor Cells (CTC) Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Circulating Tumor Cells (CTC) Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Circulating Tumor Cells (CTC) Market Size Share by Region (2017-2028)
Figure 38. China Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Circulating Tumor Cells (CTC) Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Circulating Tumor Cells (CTC) Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Circulating Tumor Cells (CTC) Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Circulating Tumor Cells (CTC) Market Size Share by Country (2017-2028)
Figure 48. Mexico Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Circulating Tumor Cells (CTC) Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Circulating Tumor Cells (CTC) Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Circulating Tumor Cells (CTC) Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Circulating Tumor Cells (CTC) Market Size Share by Country (2017-2028)
Figure 54. Turkey Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Circulating Tumor Cells (CTC) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. AdnaGen Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2017-2022)
Figure 58. Apocell Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2017-2022)
Figure 59. Biocep Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2017-2022)
Figure 60. Canopus Bioscience Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2017-2022)
Figure 61. Creatv Microtech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2017-2022)
Figure 62. Ikonisys Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2017-2022)
Figure 63. IV Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2017-2022)
Figure 64. Miltenyi Biotech Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2017-2022)
Figure 65. Nanostring Technologies Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2017-2022)
Figure 66. Rarecells Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2017-2022)
Figure 67. Vitatex Revenue Growth Rate in Circulating Tumor Cells (CTC) Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Buy
